• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸段食管鳞状细胞癌的颈部淋巴结转移不一定是不可治愈的疾病。

Cervical nodal metastasis from intrathoracic esophageal squamous cell carcinoma is not necessarily an incurable disease.

作者信息

Tong Daniel King-Hung, Kwong Dora Lai Wan, Law Simon, Wong Kam Ho, Wong John

机构信息

Department of Surgery, Li Ka Shing Faculty of Medicine, University of Hong Kong Medical Centre, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China.

出版信息

J Gastrointest Surg. 2008 Oct;12(10):1638-45; discussion 1645. doi: 10.1007/s11605-008-0654-0. Epub 2008 Aug 14.

DOI:10.1007/s11605-008-0654-0
PMID:18704592
Abstract

BACKGROUND

It remains controversial if metastatic cervical lymph nodes in patients with intrathoracic esophageal cancer signify distant metastases and are therefore incurable or if they should be regarded as regional spread with a potential for cure.

MATERIAL AND METHODS

Patients with intrathoracic esophageal squamous cell carcinoma managed from 1995 to 2007, in whom metastatic cervical lymph node spread was confirmed by fine needle aspiration cytology, were studied. Treatment strategies and outcome were reviewed.

RESULTS

There were 109 patients, of whom 98 were men. Median age was 62 years (range, 34-88). Excluding those who underwent primarily palliative treatments, there were two main groups: 22 who had upfront chemoradiation therapy and subsequent esophagectomy +/- cervical lymphadenectomy and 46 who had chemoradiation only. Significant downstaging occurred in 29 of the 68 patients (42.6%), of whom eight (11.8%) had complete pathological/clinical response. There was no mortality after esophagectomy. Median survival of patients with chemoradiation plus esophagectomy was 34.8 months compared to those with no surgery at 9.9 months, (p < 0.001). Patients with stage IV disease at presentation by virtue of nodal disease survived longer than those with the same stage because of systemic organ metastases: 9.3 vs. 3 months, (p < 0.001).

CONCLUSIONS

Prognosis of patients with metastatic cervical nodes was not uniformly dismal. Up to 20% had reasonable survival after chemoradiation and surgical resection. Stage IV disease should be revised to segregate those with nodal and systemic metastases.

摘要

背景

对于胸段食管癌患者出现的转移性颈部淋巴结,究竟是意味着远处转移因而无法治愈,还是应被视为有治愈可能的区域扩散,目前仍存在争议。

材料与方法

对1995年至2007年期间接受治疗的胸段食管鳞状细胞癌患者进行研究,这些患者经细针穿刺细胞学检查证实有转移性颈部淋巴结扩散。回顾了治疗策略及结果。

结果

共有109例患者,其中98例为男性。中位年龄为62岁(范围34 - 88岁)。排除那些主要接受姑息治疗的患者后,有两个主要组:22例患者先接受了术前放化疗,随后进行了食管切除术及±颈部淋巴结清扫术;46例患者仅接受了放化疗。68例患者中有29例(42.6%)出现显著降期,其中8例(11.8%)达到完全病理/临床缓解。食管切除术后无死亡病例。接受放化疗加食管切除术的患者中位生存期为34.8个月,而未接受手术的患者为9.9个月,(p < 0.001)。因淋巴结疾病初诊为IV期的患者比因全身器官转移处于相同分期的患者生存期更长:9.3个月对3个月,(p < 0.001)。

结论

有转移性颈部淋巴结的患者预后并非一概不佳。高达20%的患者在接受放化疗及手术切除后有合理的生存期。IV期疾病应重新分类,以区分有淋巴结转移和全身转移的患者。

相似文献

1
Cervical nodal metastasis from intrathoracic esophageal squamous cell carcinoma is not necessarily an incurable disease.胸段食管鳞状细胞癌的颈部淋巴结转移不一定是不可治愈的疾病。
J Gastrointest Surg. 2008 Oct;12(10):1638-45; discussion 1645. doi: 10.1007/s11605-008-0654-0. Epub 2008 Aug 14.
2
Distant nodal metastases from intrathoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after chemoradiotherapy.胸段食管鳞状细胞癌的远处淋巴结转移:放化疗后长期存活者的特征
J Surg Oncol. 2010 Aug 1;102(2):158-62. doi: 10.1002/jso.21588.
3
Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.在根治性食管切除术和三野淋巴结清扫术后,颈淋巴结转移在胸段食管鳞状细胞癌中被归类为区域淋巴结分期。
BMC Surg. 2014 Dec 19;14:110. doi: 10.1186/1471-2482-14-110.
4
Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study.胸段食管鳞状细胞癌的淋巴结跳跃转移:一项队列研究。
BMC Surg. 2017 May 2;17(1):49. doi: 10.1186/s12893-017-0247-5.
5
Analysis of the causes of failure after radical surgery in patients with TNM thoracic esophageal squamous cell carcinoma and consideration of postoperative radiotherapy.分析 TNM 胸段食管鳞癌根治术后失败的原因及术后放疗的考虑。
World J Surg Oncol. 2017 Oct 25;15(1):192. doi: 10.1186/s12957-017-1259-4.
6
Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.局部晚期食管癌新辅助放化疗取得主要缓解后,淋巴结微转移发生率降低。
Ann Surg Oncol. 2007 Feb;14(2):954-9. doi: 10.1245/s10434-006-9141-6. Epub 2006 Nov 11.
7
Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.局部晚期食管癌的淋巴结转移:新辅助治疗如何改变其频率和分布。
Ann Surg Oncol. 2011 Dec;18(13):3743-54. doi: 10.1245/s10434-011-1753-9. Epub 2011 May 10.
8
Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?食管癌切除术后的辅助化疗:在治疗淋巴结阳性胸段食管鳞状细胞癌中是否有作用?
J Surg Oncol. 2014 Dec;110(7):864-8. doi: 10.1002/jso.23716. Epub 2014 Jun 29.
9
Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma.上食管鳞癌的淋巴结转移模式和生存情况。
Ann Thorac Surg. 2011 Sep;92(3):1091-7. doi: 10.1016/j.athoracsur.2011.03.093. Epub 2011 Jun 25.
10
Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.临床 T1bN0M0 期食管癌患者根治性食管切除术与根治性放化疗的比较。
Ann Surg Oncol. 2012 Jul;19(7):2135-41. doi: 10.1245/s10434-012-2231-8.

引用本文的文献

1
Optimization strategies for ultrasound zoning of cervical lymph nodes in esophageal cancer: a precision medicine approach.食管癌颈淋巴结超声分区的优化策略:精准医学方法
Front Oncol. 2025 Aug 6;15:1596770. doi: 10.3389/fonc.2025.1596770. eCollection 2025.
2
Supraclavicular lymph node metastasis in esophageal carcinoma: a topic of ongoing controversy.食管癌锁骨上淋巴结转移:一个仍在争论的话题。
Front Oncol. 2025 Jan 27;15:1527625. doi: 10.3389/fonc.2025.1527625. eCollection 2025.
3
Neoadjuvant therapy combined with surgery is superior to chemoradiotherapy in esophageal squamous cell cancer patients with resectable supraclavicular lymph node metastasis: a propensity score-matched analysis.

本文引用的文献

1
Surgical outcome of patients with thoracic esophageal cancer positive for cervical lymph nodes.伴有颈部淋巴结转移的胸段食管癌患者的手术疗效
Hepatogastroenterology. 2007 Jan-Feb;54(73):100-3.
2
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.新辅助放化疗或化疗对食管癌患者的生存获益:一项荟萃分析。
Lancet Oncol. 2007 Mar;8(3):226-34. doi: 10.1016/S1470-2045(07)70039-6.
3
En-bloc esophagectomy--the three-field dissection.整块食管切除术——三野清扫术
新辅助治疗联合手术在可切除的锁骨上淋巴结转移食管鳞状细胞癌患者中优于放化疗:一项倾向评分匹配分析
Ann Transl Med. 2022 Mar;10(6):349. doi: 10.21037/atm-22-577.
4
Should the clinical significance of supraclavicular and celiac lymph node metastasis in thoracic esophageal cancer be reevaluated?胸段食管癌锁骨上和腹腔淋巴结转移的临床意义是否需要重新评估?
Thorac Cancer. 2019 Aug;10(8):1725-1735. doi: 10.1111/1759-7714.13144. Epub 2019 Jul 10.
5
Comparison of two major staging systems of esophageal cancer-toward more practical common scale for tumor staging.两种主要食管癌分期系统的比较——寻求更实用的肿瘤分期通用标准
Ann Transl Med. 2018 Feb;6(4):76. doi: 10.21037/atm.2018.01.27.
6
Efficacy and prognostic analysis of chemoradiotherapy in patients with thoracic esophageal squamous carcinoma with cervical lymph nodal metastasis alone.单纯颈淋巴结转移胸段食管鳞癌患者放化疗的疗效及预后分析
Radiat Oncol. 2014 Nov 26;9:256. doi: 10.1186/s13014-014-0256-9.
7
Unilateral cervical nodal metastasis is an independent prognostic factor for esophageal squamous cell carcinoma patients undergoing chemoradiotherapy: a retrospective study.单侧颈淋巴结转移是接受放化疗的食管鳞状细胞癌患者的独立预后因素:一项回顾性研究。
PLoS One. 2014 Jun 30;9(6):e101332. doi: 10.1371/journal.pone.0101332. eCollection 2014.
8
Clinical course and outcome after esophagectomy with three-field lymphadenectomy in esophageal cancer.食管癌三野淋巴结清扫术后的临床过程和结局。
Langenbecks Arch Surg. 2010 Apr;395(4):341-6. doi: 10.1007/s00423-010-0592-7. Epub 2010 Feb 21.
9
ESCC with metastasis in the young age of caustic ingestion of shortest duration.在腐蚀性摄入时间最短的年轻患者中发生转移的食管鳞状细胞癌。
J Gastrointest Cancer. 2010 Jun;41(2):93-5. doi: 10.1007/s12029-009-9121-8.
Surg Clin North Am. 2005 Jun;85(3):611-9, xi. doi: 10.1016/j.suc.2005.01.005.
4
A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followed by surgery or surgery alone.对接受新辅助放化疗后行手术或单纯手术治疗的局部晚期食管癌患者进行回顾性分析。
Ann Thorac Surg. 2005 Apr;79(4):1116-21. doi: 10.1016/j.athoracsur.2004.08.042.
5
Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.174例R0切除的食管癌和食管胃交界癌的三野淋巴结清扫术:对分期、无病生存期及预后的影响:呼吁对上段食管癌的TNM分类进行调整
Ann Surg. 2004 Dec;240(6):962-72; discussion 972-4. doi: 10.1097/01.sla.0000145925.70409.d7.
6
Therapeutic options for esophageal cancer.食管癌的治疗选择。
J Gastroenterol Hepatol. 2004 Jan;19(1):4-12. doi: 10.1111/j.1440-1746.2004.03154.x.
7
Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease.食管癌完全切除术后的复发模式及复发疾病的预测因素。
Cancer. 2003 Apr 1;97(7):1616-23. doi: 10.1002/cncr.11228.
8
Surgical treatment of esophageal cancer--the advent of the era of individualization.食管癌的外科治疗——个体化时代的来临。
N Engl J Med. 2002 Nov 21;347(21):1705-9. doi: 10.1056/NEJMe020130.
9
Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus.食管癌鳞状细胞癌和腺癌的三野淋巴结清扫术。
Ann Surg. 2002 Aug;236(2):177-83. doi: 10.1097/00000658-200208000-00005.
10
Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy.采用两野淋巴结清扫的食管次全切除术后的复发模式。
Br J Surg. 2000 Mar;87(3):362-73. doi: 10.1046/j.1365-2168.2000.01383-5.x.